These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2909748)

  • 1. N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor.
    Trivedi BK; Bridges AJ; Patt WC; Priebe SR; Bruns RF
    J Med Chem; 1989 Jan; 32(1):8-11. PubMed ID: 2909748
    [No Abstract]   [Full Text] [Related]  

  • 2. C2,N6-disubstituted adenosines: synthesis and structure-activity relationships.
    Trivedi BK; Bruns RF
    J Med Chem; 1989 Aug; 32(8):1667-73. PubMed ID: 2754691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor.
    Bridges AJ; Bruns RF; Ortwine DF; Priebe SR; Szotek DL; Trivedi BK
    J Med Chem; 1988 Jul; 31(7):1282-5. PubMed ID: 3385722
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor.
    van Galen PJ; Ijzerman AP; Soudijn W
    FEBS Lett; 1987 Oct; 223(1):197-201. PubMed ID: 2959564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
    Trivedi BK; Bristol JA; Bruns RF; Haleen SJ; Steffen RP
    J Med Chem; 1988 Jan; 31(1):271-3. PubMed ID: 3336027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-phenyladenosines: pronounced effect of phenyl substituents on affinity for A2 adenosine receptors.
    Kwatra MM; Leung E; Hosey MM; Green RD
    J Med Chem; 1987 May; 30(5):954-6. PubMed ID: 3572985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CNS-active 4-phenylpyranes: 9-phenyl-9-piperidino-3-oxa-7-azabicyclo[3.3.1]nonane].
    Eiden F; Schmidt M; Deus-Neumann B; Zenk MH
    Arch Pharm (Weinheim); 1987 Feb; 320(2):130-4. PubMed ID: 3034190
    [No Abstract]   [Full Text] [Related]  

  • 8. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the molecular structure of N6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity.
    Pirovano IM; IJzerman AP; Van Galen PJ; Soudijn W
    Eur J Pharmacol; 1989 May; 172(2):185-93. PubMed ID: 2767141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.
    Ong HH; Anderson VB; Wilker JC; Spaulding TC; Meyerson LR
    J Med Chem; 1980 Jul; 23(7):726-9. PubMed ID: 6249930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists.
    Moos WH; Szotek DS; Bruns RF
    J Med Chem; 1985 Oct; 28(10):1383-4. PubMed ID: 2995663
    [No Abstract]   [Full Text] [Related]  

  • 13. Catalytic enantioselective total syntheses of bisorbicillinolide, bisorbicillinol, and bisorbibutenolide.
    Hong R; Chen Y; Deng L
    Angew Chem Int Ed Engl; 2005 May; 44(22):3478-81. PubMed ID: 15861438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticholinergics: synthesis of alpha and beta isomers of 3-methyl-3-azabicyclo [3, 3, 1] nonan-9-yl esters].
    Wang XM; Yun LH; Wen GL; Zhang QK
    Yao Xue Xue Bao; 1984 Oct; 19(10):748-54. PubMed ID: 6544026
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
    Thompson RD; Secunda S; Daly JW; Olsson RA
    J Med Chem; 1991 Dec; 34(12):3388-90. PubMed ID: 1766003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and analgesic activity of derivatives of azabicycloalkanes].
    Zhou DH; Fang SN; Ge BL; Li QZ; Li ZY; Dai QY; Wu RQ; Wu YZ; Huang ZM; Chen XJ
    Yao Xue Xue Bao; 1982 Jul; 17(7):503-9. PubMed ID: 7180481
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of amino derivatives of 9,10-ethanoanthracene and 7-oxabicyclo(2.2.1)heptene.
    Kolodyńska Z; Wieniawski W
    Acta Pol Pharm; 1975; 32(2):133-7. PubMed ID: 1136820
    [No Abstract]   [Full Text] [Related]  

  • 19. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
    J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Binding of adenosine analogs with A1-type purine receptors in the guinea pig ileum].
    Poltavchenko GM; Katkov VF; Pavlov VN; Travkin OV
    Biull Eksp Biol Med; 1990 Feb; 109(2):165-7. PubMed ID: 2337653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.